Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20050388HPVENSG00000089250.20protein_codingNOS1NoNo4842A0PJJ7
B3VK56
P29475
TVIS20050392HPVENSG00000089250.20protein_codingNOS1NoNo4842A0PJJ7
B3VK56
P29475
TVIS20021051HPVENSG00000089250.20protein_codingNOS1NoNo4842A0PJJ7
B3VK56
P29475
TVIS44034700HTLV-1ENSG00000089250.20protein_codingNOS1NoNo4842A0PJJ7
B3VK56
P29475
TCGA Plot Options
Drug Information
GeneNOS1
DrugBank IDDB03144
Drug NameN(5)-[(hydroxyamino)(imino)methyl]-L-ornithine
Target IDBE0000067
UniProt IDP29475
Regulation Type
PubMed IDs17139284; 17016423; 10592235
CitationsOverington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.@@Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.@@Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
GroupsExperimental
Direct ClassificationArginine and derivatives
SMILESN[C@@H](CCCNC(=N)NO)C(O)=O
PathwaysHyperornithinemia-Hyperammonemia-Homocitrullinuria [HHH-syndrome]; Ornithine Aminotransferase Deficiency (OAT Deficiency); Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency); Hyperprolinemia Type I; Hyperprolinemia Type II; Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency); Prolidase Deficiency (PD); Arginine and Proline Metabolism; Hyperornithinemia with Gyrate Atrophy (HOGA); Prolinemia Type II; L-Arginine:Glycine Amidinotransferase Deficiency; Creatine Deficiency, Guanidinoacetate Methyltransferase Deficiency
PharmGKB
ChEMBLCHEMBL260629